Calumet, Inc. CLMT
Set alert
46.81 USD +0.08 +0.16%
As of Nov 3, 11:45 AM ET
46.38 Day range 47.30
17.85 52-week range 59.87
- YTD
- +135.56%
- 1 year
- +132.98%
- Open
- 47.04
- Prev close
- 46.73
- Mkt cap
- 4.13B
- Vol
- 171.92K
- Avg vol
- 1.41M
- EPS
- -1.55
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 46.38
- High
- 47.30
- Forward P/E
- 14.60
- Beta
- 0.69
- Short ratio
- 2.83
- Inst. own
- 52.12%
- Dividend
- 0.00
- Ex-div date
- Jan 28, 2016
- Earnings
- Nov 6, 2026
- 50-d avg
- 53.74
- 200-d avg
- 38.53
- 1y target
- 55.80
3M chart
Events in this range
- Aug 7, 2026Earnings: -1.09; estimate 0.06741; surprise -1716.97%
- Aug 12, 2026Rating: TD Cowen · Hold → Hold
- Aug 18, 2026Rating: Goldman Sachs · Neutral → Neutral
- Aug 25, 2026Rating: UBS · Neutral → Neutral
- Sep 2, 2026Rating: HC Wainwright & Co. · Buy → Buy
Signals (16)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bearish | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 19, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 13, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bullish | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 22, 2026 | 1 month ago |
| RSI: Overbought | Sep 9, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 18, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 7, 2026 | 2 months ago |
Financial health
Altman Z-Score
1.03 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 4
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -50.9×
FY 2016 5y median -7.9× FY 2025
P/S 0.4×
FY 2016 5y median 0.3× FY 2025
P/B -2.4×
FY 2016 5y median -2.6× FY 2025
P/FCF 30.5×
FY 2016 5y median -5.0× FY 2025
EV/EBITDA 17.0×
FY 2016 5y median 17.0× FY 2025
EV/Sales 1.0×
FY 2016 5y median 0.9× FY 2025
FCF Yield 3.3%
FY 2016 5y median -12.2% FY 2025
Profitability
Gross Margin 5.9%
FY 2016 5y median 5.9% FY 2025
Operating Margin 1.3%
FY 2016 5y median 1.3% FY 2025
Net Margin -0.8%
FY 2016 5y median -3.6% FY 2025
ROE 4.6%
FY 2016 5y median 31.1% FY 2025
ROIC 0.7%
FY 2016 5y median 0.7% FY 2025
ROA -1.3%
FY 2016 5y median -6.2% FY 2025
Growth (YoY)
Revenue -1.2%
FY 2016 FY 2025
Operating Income 569.1%
FY 2016 FY 2025
EPS (diluted) 85.4%
FY 2016 FY 2025
Free Cash Flow 146.0%
FY 2016 FY 2025
Financial Health
Current Ratio 1.0×
FY 2016 5y median 0.7× FY 2025
Quick Ratio 0.6×
FY 2016 5y median 0.3× FY 2025
Debt / Equity -3.4×
FY 2016 5y median -3.5× FY 2025
Net Debt / EBITDA 9.8×
FY 2016 5y median 9.8× FY 2025
Interest Coverage 0.3×
FY 2016 5y median 0.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
